AMRO Stock Analysis Today
Updated Nov 10, 2026 · trends, key levels, insider activity and news
Is AMRO bullish or bearish today?
Daily trend: Neutral
SEPT signal: Institutional Drive · Strong Bullish
AMRO trend by timeframe
| Daily | Neutral |
|---|---|
| 4 hour | Leaning Bearish |
| 1 hour | Strong Bearish |
| 15 min | Strong Bearish |
| 5 min | Strong Bullish |
Trends are calculated from price structure and update during market hours.
AMRO support and resistance levels
Resistance (above)
—
Support (below)
$6.151 touches
Upside zones: $6.98 / $7.24 / $7.51
See all levels on the live chart →Latest AMRO news and filings
- EarningsBenzinga
Amaero holds Q3 2026 earnings call
Amaero discussed its third-quarter 2026 results during an earnings call. The headline gives no figures or details from the call.
- SEC FilingSECAmaero Inc. filed a report on a major company event (Form 8-K)
Form 8-K tells shareholders about important events such as deals, leadership changes or results.
- AnalystBenzinga
Supernus Pharmaceuticals receives bullish analyst coverage initiation
An analyst started covering Supernus Pharmaceuticals with a positive view. The initiation was among several analyst coverage starts noted for Monday.
- AnalystBenzinga
Baird starts Amaero coverage with Outperform rating and $9 price target
Baird began covering Amaero and gave the stock an Outperform rating. The firm set a price target of $9 per share.
Live AMRO chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is AMRO bullish or bearish today?
AMRO daily trend: Neutral. SEPT signal: Institutional Drive (Strong Bullish). Updated Nov 10, 2026.
What is AMRO's trend on each timeframe?
Daily: Neutral; 4 hour: Leaning Bearish; 1 hour: Strong Bearish; 15 min: Strong Bearish; 5 min: Strong Bullish.
What are AMRO support and resistance levels?
Support: $6.15. Last price $6.42.
What is the latest news on AMRO?
Nov 9, 2026: Amaero holds Q3 2026 earnings call · Nov 9, 2026: Amaero Inc. filed a report on a major company event (Form 8-K) · Nov 9, 2026: Supernus Pharmaceuticals receives bullish analyst coverage initiation